Interventional Neuroradiology, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
NIHR Nottingham Biomedical Research Centre, Nottingham, UK.
J Neurointerv Surg. 2023 Mar;15(3):233-237. doi: 10.1136/neurintsurg-2021-018591. Epub 2022 Feb 15.
The safety and functional outcome of endovascular thrombectomy (EVT) in the very late (VL; >24 hours) time window from ischemic stroke onset remains undetermined.
Using data from a national stroke registry, we used propensity score matched (PSM) individual level data of patients who underwent EVT, selected with CT perfusion or non-contrast CT/CT angiography, between October 2015 and March 2020. Functional and safety outcomes were assessed in both late (6-24 hours) and VL time windows. Subgroup analysis was performed of imaging selection modality in the VL time window.
We included 1150 patients (late window: 1046 (208 after PSM); VL window: 104 (104 after PSM)). Compared with EVT treatment initiation between 6 and 24 hours, patients treated in the VL window had similar modified Rankin Scale (mRS) scores at discharge (ordinal shift; common OR=1.08, 95% CI 0.69 to 1.47, p=0.70). No significant differences in achieving good functional outcome (mRS ≤2 at discharge; 28.8% (VL) vs 29.3% (late), OR=0.97, 95% CI 0.58 to 1.64, p=0.93), successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b-3) (p=0.77), or safety outcomes of symptomatic intracranial hemorrhage (p=0.43) and inhospital mortality (p=0.23) were demonstrated. In the VL window, there was no significant difference in functional outcome among patients selected with perfusion versus those selected without perfusion imaging (common OR=1.38, 95% CI 0.81 to 1.76, p=0.18).
In this real world study, EVT beyond 24 hours from stroke onset or last known well appeared to be feasible, with comparable safety and functional outcomes to EVT initiation between 6 and 24 hours. Randomized trials assessing the efficacy of EVT in the VL window are warranted, but may only be feasible with a large international collaborative approach.
超窗(>24 小时)时间窗内进行血管内血栓切除术(EVT)的安全性和功能预后仍不确定。
利用全国性卒中登记处的数据,我们采用 CT 灌注或非对比 CT/CT 血管造影选择的患者的倾向评分匹配(PSM)个体水平数据,在 2015 年 10 月至 2020 年 3 月之间进行 EVT。在晚期(6-24 小时)和 VL 时间窗内评估功能和安全性结果。在 VL 时间窗内进行了影像学选择方式的亚组分析。
我们纳入了 1150 名患者(晚期窗口:1046 名[PSM 后 208 名];VL 窗口:104 名[PSM 后 104 名])。与 6 至 24 小时之间进行 EVT 治疗相比,在 VL 时间窗内接受治疗的患者出院时的改良 Rankin 量表(mRS)评分相似(等级偏移;常见比值比=1.08,95%CI 0.69 至 1.47,p=0.70)。在实现良好的功能预后(出院时 mRS≤2;28.8%(VL)与 29.3%(晚期),比值比=0.97,95%CI 0.58 至 1.64,p=0.93)、成功再灌注(改良脑梗死溶栓评分 2b-3)(p=0.77)或症状性颅内出血(p=0.43)和住院死亡率(p=0.23)方面,均未显示出显著差异。在 VL 时间窗内,灌注成像选择的患者与未选择灌注成像的患者之间的功能预后无显著差异(常见比值比=1.38,95%CI 0.81 至 1.76,p=0.18)。
在这项真实世界的研究中,超窗(>24 小时)时间窗内进行的 EVT 似乎是可行的,其安全性和功能预后与 6 至 24 小时之间进行的 EVT 启动相似。需要进行评估超窗内 EVT 疗效的随机试验,但可能仅在采用大型国际协作方法时才可行。